Ozen Alaattin, Halici Mehmet
Department of Radiation Oncology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey.
Breast Cancer Res Treat. 2025 May;211(1):271-272. doi: 10.1007/s10549-025-07670-1. Epub 2025 Mar 3.
We read with great interest the recent article, "Comparison of survival between unilateral and bilateral breast cancers using propensity score matching: a retrospective single-center analysis" by Ozler et al. This study addresses an important gap in the literature by comparing disease-free survival (DFS) and overall survival (OS) between unilateral and bilateral breast cancer, and the use of propensity score matching (PSM) strengthens the validity of the findings. However, we would like to share several reflections that we believe can enhance the interpretation and future application of this research.
我们饶有兴趣地阅读了Ozler等人最近发表的文章《使用倾向评分匹配比较单侧和双侧乳腺癌的生存率：一项回顾性单中心分析》。这项研究通过比较单侧和双侧乳腺癌的无病生存期（DFS）和总生存期（OS），填补了文献中的一个重要空白，并且倾向评分匹配（PSM）的使用增强了研究结果的有效性。然而，我们想分享一些看法，我们认为这些看法可以加强对这项研究的解读及其未来应用。
